Access
To read this story in full you will need to login or make a payment (see right).
Commentary
Nature 453, 851-852 (12 June 2008) | doi:10.1038/453851a; Published online 11 June 2008
Open Innovation Challenges
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
- More Challenges
- Powered by:
nature jobs
Structural & Computational Biology
- Indian Institute of Chemical Biology
- Kolkata India
Postdoctoral Fellowship
- Lovelace Respiratory Research Institute
- Albuquerque, New Mexico
Follow the leader
Kaori Tsuji1 & Kiichiro Tsutani2
- Kaori Tsuji is at the Health Care Science Institute, Akasaka NOA 5F, 3-2-12 Akasaka, Minato-ku, Tokyo 107-0052, Japan.
- Kiichiro Tsutani is at the University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Abstract
If Japan is to become a front-runner in pharmaceutical development, it must not only speed up its approval of new drugs, but also enhance its own research capabilities, argue Kaori Tsuji and Kiichiro Tsutani.
How long should a therapy take to journey from lab bench to bedside? The obvious need to prove the safety and efficacy of an investigational therapeutic product has notoriously led to delays that that can be aggravating for both drug developers and patients.
To read this story in full you will need to login or make a payment (see right).
